+489.1%
DDOG vs MRNA
+712.9%
-223.8%
-68.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +5.4% | -5.6% | -0.6% |
| 7D | +3.9% | -1.1% | +5.0% | +3.9% |
| 30D | -8.2% | +126.1% | -134.3% | -19.4% |
| 3M | -5.6% | +190.0% | -195.6% | -20.6% |
| 6M | +73.5% | +157.2% | -83.7% | +47.7% |
| YTD | +62.7% | +388.2% | -325.5% | +24.2% |
| 1Y | +59.0% | +467.0% | -408.1% | +17.7% |
| 3Y | +117.1% | +36.1% | +81.1% | +89.4% |
| 5Y | +61.3% | -68.0% | +129.3% | +56.8% |
| All | +489.1% | +712.9% | -223.8% | +499.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling